The objective of this research is to test the hypothesis that the plasma membrane may represent a sensitive site for anticancer drug action. The work focuses on adriamycin and related anthracyclines. Damage to nuclear DNA has been considered to be a primary target for adriamycin action, but there is also a large body of evidence suggesting that the structure and functions of biological membranes are also sensitive to adriamycin disruption. This laboratory has shown that adriamycin immobilized on large polymers can be actively cytoxic under conditions where it does not enter the cell and bind to DNA, but only accesses the cell surface. Experiments are proposed to put this finding to a practical test by using the immobilized drug as a direct therapeutic agent in animals. The polymer bound drug will be used as an intracavitary agent to treat ovarian epithelial malignancies, mesothelioma, and ascites tumors. Preliminary results show that immobilization retains the anticancer activity of adriamycin, and intraperitoneal administration lacks significant toxic side effects. The second major aim of this research is to study the role of phosphatidyl inositol (PI) turnover in mediating the cytotoxic action of free adriamycin. Drug treatment enhances PI turnover, leading to the generation of two second messengers- inositol trisphosphate (Ip3) and diacylglycerol (DG). The function of Ip3 is to mobilize intracellular free Ca++, but these processes appear to be decoupled in the presence of adriamycin. The other messenger, DG, activates protein kinase C (PKC). The activity of this enzyme appears to be linked to the induction of adriamycin cytotoxicity, so experiments are proposed to determine the role of the following properties in drug mechanism: (1) cofactor requirements, (2) translocation between cytoplasm and membrane, (3) isozyme distribution, (4) phosphorylation of topoisomerase II and other substrates. These experiments will provide a detailed understanding of how the PI/PKC signal transduction pathway functions to mediate the cytotoxic cascade induced by adriamycin.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA044729-04
Application #
3187478
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1987-06-01
Project End
1993-05-31
Budget Start
1990-06-01
Budget End
1991-05-31
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
Schools of Medicine
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Vichi, P J; Tritton, T R (1993) Protection from adriamycin cytotoxicity in L1210 cells by brefeldin A. Cancer Res 53:5237-43
Dolci, E D; Abramson, R; Xuan, Y et al. (1993) Anomalous expression of P-glycoprotein in highly drug-resistant human KB cells. Int J Cancer 54:302-8
Bhushan, A; Abramson, R; Chiu, J F et al. (1992) Expression of c-fos in human and murine multidrug-resistant cells. Mol Pharmacol 42:69-74
Tritton, T R (1991) Cell surface actions of adriamycin. Pharmacol Ther 49:293-309
Constantinides, P P; Wang, Y Y; Burke, T G et al. (1990) Transverse location of anthracyclines in lipid bilayers. Paramagnetic quenching studies. Biophys Chem 35:259-64
Posada, J; Vichi, P; Tritton, T R (1989) Protein kinase C in adriamycin action and resistance in mouse sarcoma 180 cells. Cancer Res 49:6634-9
Posada, J A; McKeegan, E M; Worthington, K F et al. (1989) Human multidrug resistant KB cells overexpress protein kinase C: involvement in drug resistance. Cancer Commun 1:285-92
Hacker, M P; Lazo, J S; Pritsos, C A et al. (1989) Immobilized adriamycin: toxic potential in vivo and in vitro. Sel Cancer Ther 5:67-72
Vichi, P; Tritton, T R (1989) Stimulation of growth in human and murine cells by adriamycin. Cancer Res 49:2679-82
Dreyer, R; Hawrot, E; Sartorelli, A C et al. (1988) Sedimentation field flow fractionation of fused unilamellar vesicles: comparison with electron microscopy and gel filtration. Anal Biochem 175:433-41

Showing the most recent 10 out of 12 publications